Prognostic significance of the pretreatment pan-immune-inflammation value in colorectal cancer patients: an updated meta-analysis

QR Code

Prognostic significance of the pretreatment pan-immune-inflammation value in colorectal cancer patients: an updated meta-analysis

BackgroundThe prognostic importance of the pretreatment pan-immune-inflammation value (PIV) in colorectal cancer has been extensively documented, yet its role remains unclear. This study aims to conduct an updated meta-analysis to elucidate the relationship between the pretreatment PIV and long-term...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jing Li, Huayang Pang, Hao Sun, Xiaoyu Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Oncology
Subjects:	colorectal cancer pan-immune-inflammation value overall survival disease-free survival cancer-specific survival meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1599075/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The association between neutrophil percentage to albumin ratio and progression-free survival and overall survival in colorectal cancer patients: a retrospective cohort study
by: Hailun Xie, et al.
Published: (2025-07-01)

Combining Preoperative and Postoperative Prognostic Nutritional Index as an Improved Prognostic Factor for Overall Survival in Patients with Colorectal Cancer
by: Lee JM, et al.
Published: (2025-07-01)

METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
by: S. N. Tadzhibov, et al.
Published: (2017-06-01)

Survival of retinoblastoma patients: a cohort study by two Russian medical centers
by: S. V. Saakyan, et al.
Published: (2021-03-01)

The influence of some clinical and morphological prognosis factors on the 5-year survival of patients with stage I cervical cancer
by: E. V. Makarova, et al.
Published: (2019-12-01)

Analysis of zebrafish homologs within the human genome provides valuable insights into exploring pan-cancer alternative splicing events as prognostic markers and therapeutic targets
by: Yanjun Liang, et al.
Published: (2025-08-01)

Prognostic Factors Influencing the Efficacy of Regorafenib in the Treatment of Metastatic Colorectal Cancer
by: Nadiye SEVER, et al.
Published: (2025-06-01)

The expression and prognostic predictive value of PD-L2 in patients undergoing radical gastric cancer surgery
by: Xiuping Zhang, et al.
Published: (2025-12-01)

EXPRESSION OF CANCER-TESTIS GENES PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 IN PATIENTS WITH MULTIPLE MYELOMA, THEIR INFLUENCE ON OVERALL SURVIVAL AND RELAPSE RATE
by: A. A. Solodovnik, et al.
Published: (2018-07-01)

Mutations of the PIK3CA gene in patients with breast cancer in the Krasnoyarsk region
by: A. V. Zyuzyukina, et al.
Published: (2024-07-01)

Impact of blood lipid levels on breast cancer prognosis: a systematic review and meta-analysis
by: Jiaqing Song, et al.
Published: (2025-07-01)

The role of Lobectomy in Glioblastoma management: A Retrospective series
by: Christina K. Arvaniti, et al.
Published: (2025-01-01)

Predictive Value of the CA-125 Elimination Rate Constant K (KELIM) in Predicting Progression-Free Survival and Overall Survival in Epithelial Ovarian Cancer
by: Necim Yalcin, et al.
Published: (2025-07-01)

Estimating long-term overall survival with olaparib as maintenance therapy in patients with newly diagnosed advanced ovarian cancer with BRCA mutations
by: N. A. Avxentyev, et al.
Published: (2021-10-01)

Clinicopathological and prognostic significance of epithelial cell transforming sequence 2 expression in cancers: a systematic review and meta-analysis
by: Bin Li, et al.
Published: (2019-12-01)

Incidence, characteristics, and survival in early- and late-onset colorectal cancer
by: Tanja Hukkinen, et al.
Published: (2025-07-01)

INFLUENCE OF RISK FACTORS FOR DISEASE PROGRESSION ON TREATMENT RESULTS IN PATIENTS WITH PROSTATE CANCER
by: R. M. Isargapov, et al.
Published: (2021-06-01)

The role of neoadjuvant chemotherapy of triple-negative breast cancer in St. Petersburg City Clinical Oncological Dispensary
by: A. G. Manikhas, et al.
Published: (2016-09-01)

The Naples Prognostic Score Exerts a Significant Impact on the Prognosis of Patients Diagnosed with External Auditory Canal Carcinoma After Surgery
by: Xu XL, et al.
Published: (2025-05-01)

Preoperative prognostic value of alfa-fetoprotein density in patients with hepatocellular carcinoma undergoing radiofrequency ablation
by: Bo-Wen Zhuang, et al.
Published: (2022-12-01)

The Prognostic Value of Perioperative Factors on Biochemical Recurrence in Patients Undergoing Radical Prostatectomy
by: Pyrgidis N, et al.
Published: (2025-05-01)

High-dose versus Standard-dose Daunorubicin in Induction Chemotherapy for Acute Myeloid Leukemia: A Meta-Analysis
by: Bibi Kulsoom, et al.
Published: (2025-06-01)

Comprehensive Analysis of Lung Cancer Metastasis: Sites, Rates, Survival, and Risk Factors—A Systematic Review and Meta‐Analysis
by: Shilin Wang, et al.
Published: (2025-07-01)

Trajectories of Cancer Antigen 125 (CA125) Within 3 and 6 Months After the Initiation of Chemotherapy Treatment for Advanced Ovarian Cancer and Clinical Outcomes: A Secondary Analysis of Data from a Phase III Clinical Trial
by: Chang Yin, et al.
Published: (2025-07-01)

Genes copy number variation in colorectal cancer patients as a marker of the disease clinical outcome and response to therapy
by: A. A. Maslov, et al.
Published: (2022-06-01)

The Importance of Pan‐Immune‐Inflammation Value Score in Locally Advanced Rectal Cancer
by: Mahmut Uçar, et al.
Published: (2025-07-01)

Comparative analysis of survival rates of pre- and postmenopausal patients with early breast cancer
by: N. B. Bekkeldieva, et al.
Published: (2025-05-01)

COMBINED TREATMENT OF OPERABLE RECTAL CANCER WITH NEGATIVE PROGNOSIS FACTORS: A PROSPECTIVE STUDY
by: S. O. Kochkina, et al.
Published: (2021-08-01)

Experience in the use of olaparib poly (ADP-ribose) polymerase inhibitors in maintenance therapy of BRCA-associated ovarian cancer
by: V. N. Zhurman, et al.
Published: (2023-02-01)

Experience of using chemotherapy treatment for the first recurrence of ovarian cancer
by: V. N. Zhurman
Published: (2025-01-01)

Comparative long-term outcomes of first-line CDK4/6 inhibitors plus endocrine therapy versus endocrine therapy in patients with HR+/HER2-metastatic or advanced breast cancer: a meta-analysis
by: Xiaojian Wang, et al.
Published: (2025-07-01)

Relationship between the transcriptional activity of СT-genes and survival in colorectal cancer patients
by: D. S. Kutilin, et al.
Published: (2022-03-01)

Effect of prognostic factors on survival rates in patients with non-clear cell renal cell carcinoma
by: D. V. Semenov, et al.
Published: (2025-03-01)

Meta-analysis of the prognostic efficacy of daratumumab combined with standard therapy in high-risk multiple myeloma
by: Hongmei Zhou, et al.
Published: (2025-12-01)

Oncological aid for colorectal cancer patients in Tomsk area: ways of cancer prevention
by: L. D. Zhuykova, et al.
Published: (2014-12-01)

Survival of patients with bilateral renal cell cancer after nephro-preserving surgery
by: F. S. Ashyrova, et al.
Published: (2021-06-01)

A Novel Survival Prediction Nomogram Based on the Naples Prognostic Score and Clinicopathological Factors for Postoperative Hypopharyngeal Squamous Cell Carcinoma Patients
by: Xu XL, et al.
Published: (2025-06-01)

THE MAIN PARAMETERS OF CELLULAR IMMUNITY IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER: RELATIONSHIP WITH EFFICIENCY OF CHEMOTHERAPY
by: A. I. Chertkova, et al.
Published: (2018-11-01)

Lenvatinib in advanced radioiodine-refractory differentiated thyroid cancer: what’s new?
by: E. V. Borodavina, et al.
Published: (2024-12-01)

Profiles of survival prediction in glioblastoma
by: Franziska Loebel, et al.
Published: (2025-01-01)